Head-to-head · Cost-Efficiency Index
Vitara RX vs NewSelf
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Vitara RX
Value-first shoppers who want the cheapest all-50 price on both molecules and refuse to trade away pharmacy verification to get it.
Visit Vitara RXNewSelf
Budget shoppers who want a verified all-50 program and one of the lowest disclosed tirzepatide prices in the value tier.
Visit NewSelfThe verdict
Vitara RX and NewSelf tie on the Cost-Efficiency Index at 87/100, so neither wins outright on the numbers. For most shoppers we'd start with Vitara RX (ranked #5, a hair above #6) — Value-first shoppers who want the cheapest all-50 price on both molecules and refuse to trade away pharmacy verification to get it. But NewSelf is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Vitara RX.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Vitara RX | NewSelf |
|---|---|---|
| Cost-Efficiency Index | 87/100 | 87/100 |
| Semaglutide / mo | $99/mo | $100/mo |
| Tirzepatide / mo | $149/mo | $144/mo |
| Semaglutide / yr (modeled) | $1,188 | $1,200 |
| Tirzepatide / yr (modeled) | $1,788 | $1,728 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #5 | #6 |
Vitara RX
87/100Where the value is
- $99 semaglutide and $149 tirzepatide — among the lowest combined prices on the board, and cheaper on tirzepatide than most sub-$100-sema rivals
- Nationwide all-50 access with both molecules disclosed for clean year-one cost modeling
- LegitScript-certified — budget pricing without the unverified-pharmacy asterisk that dogs the cheapest tier
The tradeoffs
- Compounded only — no FDA-approved brand-name or oral/sublingual route
- Lower-profile newcomer without a long public track record
NewSelf
87/100Where the value is
- $100 semaglutide / $144 tirzepatide — one of the cheapest verified combined prices on the board
- Nationwide all-50 coverage with both molecules published up front
- LegitScript-certified pharmacy behind the low price
The tradeoffs
- Compounded only — no brand-name or oral option
- Newer consumer brand with a thin public track record
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.